SCHEMBL5429247

SCHEMBL5429247

Cc1cc2nc(Cl)cc(N)c2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 2/20 0.37
TDP1 Q9NUW8 2/20 0.32
ALDH1A1 P00352 2/20 0.32
NR4A2 P43354 1/20 0.32
FABP6 P51161 1/20 0.32
CYP2A6 P11509 1/20 0.32
KEAP1 Q14145 1/20 0.32
KDM4E B2RXH2 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
TERT O14746 1/20 0.31
MAP4K1 Q92918 1/20 0.30
HTT P42858 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30
GAA P10253 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
HTR3E A5X5Y0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5355865 0.70 ALDH1A1 (0.44) ALDH1A1NR4A2FABP6KDM4ECYP3A4
SCHEMBL5775761 0.69 NPY5R (0.50) NPY5RTDP1ALDH1A1KDM4EHTT
SCHEMBL20712932 0.69 NPY5R (0.39) NPY5RTDP1ALDH1A1KDM4EHTT
SCHEMBL31078313 0.69 HRH4 (0.46) TDP1ALDH1A1NR4A2CYP2A6KEAP1
SCHEMBL31078356 0.68 DYRK1A (0.40) TDP1NR4A2KDM4EHTR3EHTR3B
SCHEMBL23773829 0.67 KMT2A (0.42) NPY5RTDP1SMN1; SMN2GAA
SCHEMBL3125699 0.67 FABP6 (0.47) ALDH1A1FABP6KDM4ECYP3A4
SCHEMBL4008095 0.65 KEAP1 (0.41) ALDH1A1FABP6CYP2A6KEAP1KDM4E
SCHEMBL22601387 0.64 NPY5R (0.39) NPY5RTDP1FABP6CYP2A6KEAP1
SCHEMBL21885846 0.64 ALDH1A1 (0.50) ALDH1A1MAP4K1HTTADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287726-A1 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines ALTANA PHARMA AG (DE) 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287726-A1 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines GIPR, VIP, PGC NPY5R 26/4885TDP1 4580/4885ALDH1A1 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.